I wonder whether the market will finally find out whether Lazard has secured a role on the AbbVie/Shire deal?
(for readers wondering why I have posited this question it might be worthwhile clicking on the link to this previous article: http://betaville123.blogspot.co.uk/2014/06/whats-missing-from-abbvies-27-billion.html).
A cheeky financial blog with stories about deals, dealmakers and anything else I find interesting. Edited by Ben Harrington. [Disclaimer - the information on Betaville does not constitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions.]
Showing posts with label Amgen. Show all posts
Showing posts with label Amgen. Show all posts
Monday, 14 July 2014
Subscribe to:
Comments (Atom)